NZ534479A - Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan - Google Patents
Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespanInfo
- Publication number
- NZ534479A NZ534479A NZ534479A NZ53447903A NZ534479A NZ 534479 A NZ534479 A NZ 534479A NZ 534479 A NZ534479 A NZ 534479A NZ 53447903 A NZ53447903 A NZ 53447903A NZ 534479 A NZ534479 A NZ 534479A
- Authority
- NZ
- New Zealand
- Prior art keywords
- age
- organs
- sodium
- heart failure
- ace inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Disclosed is a cariporide (sodium-hydrogen exchanger) and ramipril (angiotensin converting enzyme inhibitor) combination product. The use of the preparation is disclosed to be for preventing or delaying age-related dysfunctions of organs, especially heart failure, and for prolonging lifespan.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10204571 | 2002-02-04 | ||
PCT/EP2003/000587 WO2003066045A1 (en) | 2002-02-04 | 2003-01-22 | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ534479A true NZ534479A (en) | 2006-03-31 |
Family
ID=27674558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ534479A NZ534479A (en) | 2002-02-04 | 2003-01-22 | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1474134B1 (en) |
JP (1) | JP4733348B2 (en) |
KR (1) | KR20040083498A (en) |
CN (1) | CN1319528C (en) |
AR (1) | AR038387A1 (en) |
AT (1) | ATE520398T1 (en) |
AU (1) | AU2003244430A1 (en) |
BR (1) | BR0307443A (en) |
CA (1) | CA2474888A1 (en) |
CO (1) | CO5601009A2 (en) |
HR (1) | HRP20040702A2 (en) |
HU (1) | HUP0402593A2 (en) |
MA (1) | MA27170A1 (en) |
MX (1) | MXPA04007569A (en) |
NO (1) | NO20043698L (en) |
NZ (1) | NZ534479A (en) |
PE (1) | PE20040188A1 (en) |
PL (1) | PL370488A1 (en) |
RS (1) | RS68204A (en) |
RU (1) | RU2004126702A (en) |
TW (1) | TW200306850A (en) |
WO (1) | WO2003066045A1 (en) |
ZA (1) | ZA200406066B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201502031XA (en) * | 2010-03-31 | 2015-05-28 | Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0855392A3 (en) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them |
DE19734693A1 (en) * | 1997-08-11 | 1998-01-22 | Hoechst Marion Roussel De Gmbh | Use of cariporide to treat cardiac and non-cardiac disease |
DE19737224A1 (en) * | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmaceutical preparation for cardiovascular treatment |
US6011059A (en) * | 1997-12-24 | 2000-01-04 | Bristol-Myers Squibb Company | Acyl guanidine sodium/proton exchange inhibitors and method |
DE19859727A1 (en) * | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | The use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the prevention of age-related organ dysfunctions, age-related illnesses for the prolongation of life |
-
2003
- 2003-01-22 AU AU2003244430A patent/AU2003244430A1/en not_active Abandoned
- 2003-01-22 PL PL03370488A patent/PL370488A1/en not_active Application Discontinuation
- 2003-01-22 RS YUP-682/04A patent/RS68204A/en unknown
- 2003-01-22 RU RU2004126702/15A patent/RU2004126702A/en not_active Application Discontinuation
- 2003-01-22 WO PCT/EP2003/000587 patent/WO2003066045A1/en active Application Filing
- 2003-01-22 KR KR10-2004-7012005A patent/KR20040083498A/en not_active Application Discontinuation
- 2003-01-22 JP JP2003565469A patent/JP4733348B2/en not_active Expired - Fee Related
- 2003-01-22 CN CNB03803185XA patent/CN1319528C/en not_active Expired - Fee Related
- 2003-01-22 HU HU0402593A patent/HUP0402593A2/en unknown
- 2003-01-22 BR BR0307443-9A patent/BR0307443A/en not_active IP Right Cessation
- 2003-01-22 AT AT03737262T patent/ATE520398T1/en active
- 2003-01-22 CA CA002474888A patent/CA2474888A1/en not_active Abandoned
- 2003-01-22 NZ NZ534479A patent/NZ534479A/en unknown
- 2003-01-22 EP EP03737262A patent/EP1474134B1/en not_active Expired - Lifetime
- 2003-01-22 MX MXPA04007569A patent/MXPA04007569A/en not_active Application Discontinuation
- 2003-01-29 TW TW092101906A patent/TW200306850A/en unknown
- 2003-01-31 AR ARP030100296A patent/AR038387A1/en unknown
- 2003-01-31 PE PE2003000115A patent/PE20040188A1/en not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27801A patent/MA27170A1/en unknown
- 2004-07-29 ZA ZA200406066A patent/ZA200406066B/en unknown
- 2004-08-03 HR HR20040702A patent/HRP20040702A2/en not_active Application Discontinuation
- 2004-08-03 CO CO04075091A patent/CO5601009A2/en not_active Application Discontinuation
- 2004-08-31 NO NO20043698A patent/NO20043698L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200406066B (en) | 2005-06-08 |
HRP20040702A2 (en) | 2005-04-30 |
NO20043698L (en) | 2004-08-31 |
PE20040188A1 (en) | 2004-05-17 |
EP1474134B1 (en) | 2011-08-17 |
KR20040083498A (en) | 2004-10-02 |
BR0307443A (en) | 2005-01-04 |
MXPA04007569A (en) | 2004-11-01 |
CN1694697A (en) | 2005-11-09 |
CN1319528C (en) | 2007-06-06 |
EP1474134A1 (en) | 2004-11-10 |
JP4733348B2 (en) | 2011-07-27 |
ATE520398T1 (en) | 2011-09-15 |
JP2005519072A (en) | 2005-06-30 |
RS68204A (en) | 2007-02-05 |
HUP0402593A2 (en) | 2005-04-28 |
CA2474888A1 (en) | 2003-08-14 |
CO5601009A2 (en) | 2006-01-31 |
AU2003244430A1 (en) | 2003-09-02 |
MA27170A1 (en) | 2005-01-03 |
WO2003066045A1 (en) | 2003-08-14 |
AR038387A1 (en) | 2005-01-12 |
RU2004126702A (en) | 2005-04-20 |
TW200306850A (en) | 2003-12-01 |
PL370488A1 (en) | 2005-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG148857A1 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
WO2005049022A3 (en) | Use of dipeptidyl peptidase iv inhibitors | |
WO2004033632A3 (en) | Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) | |
IL179607A0 (en) | Indoles useful in the treatment of inflammation | |
ZA200501677B (en) | Hydantoin derivatives and their use as TACE inhibitors. | |
TR199902923T2 (en) | Yumu�ak kas h�cresi�o�almas� olarak (imidazole-5-yl)methyl-2-quinolinone trevleri inhibitor. | |
PL376129A1 (en) | Pyridazinone derivatives as gsk-3beta inhibitors | |
GEP20063767B (en) | Spiro-Hydantoin Compounds Useful as Anti-Inflammatory Agents | |
AU2003261434A1 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
AU2003292154A1 (en) | Fungicidal combinations for crop potection | |
MX2007009777A (en) | Hsp90-inhibiting triazole derivatives. | |
WO2006113470A3 (en) | Cancer treatment by combined inhibition of proteasome and telomerase activities | |
AU2003220401A1 (en) | Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases | |
AR039428A1 (en) | PERINDOPRILE SALT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
NO971444L (en) | Inhibitor of stem cell proliferation and applications thereof | |
AU2003269628A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
NO20052549L (en) | Use of a PPARalpha agonist and metformin for reducing serum triglycerides. | |
MXPA04003365A (en) | Combinations comprising cox-2 inhibitors and aspirin. | |
NZ534479A (en) | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan | |
WO2002102301A3 (en) | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof | |
MX2008002066A (en) | New crystalline form of perindopril erbumine. | |
AU2003217916A8 (en) | Stable formulations of angiotensin converting enzyme (ace) inhibitors | |
AU2003242592A1 (en) | Amide derivatives as inhibitors of the enzymatic activity of renin | |
WO2004037233A3 (en) | Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases | |
EP1500402A4 (en) | Cell death inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |